Fig. 3From: A precise molecular subtyping of ulcerative colitis reveals the immune heterogeneity and predicts clinical drug responsesCrossICC assigned UC into three stable subtypes. a–c CrossICC identified subtypes in training cohorts a GSE87466, b GSE107499 and c GSE75214. d–e CrossICC validated the stability of subtypes in validation cohorts d GSE83687 and e GSE126124. f The application of CrossICC on a small FDUHS cohort quantified by RNA-seq. g–i GO analysis of the feature genes of g Subtype 1, h Subtype 2 and i Subtype 3Back to article page